Comparing opiate users in methadone treatment with untreated opiate users: Results of a follow-up study with a Toronto opiate user cohort

Canadian Journal of Public Health

Volumn 90, Issue 5, 1999, Pages 299-303

  Fischer, Benedikt ^a   Gliksman, Louis ^b   Rehm, Jürgen ^b   Daniel, Natalie ^b   Medved, Wendy ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE; OPIATE;

ARTICLE; CANADA; DRUG ABUSE; DRUG OVERDOSE; FEMALE; HEALTH CARE COST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; OPIATE ADDICTION; PUBLIC HEALTH;

EID: 0032785982     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03404513     Document Type: Article

References (22)

1. Cain V. Report of the Task Force into Illicit Narcotic Overdose Deaths in British Columbia. Province of British Columbia: Office of the Chief Coroner, 1994.
2. Hankins C, Barlow K, Black S, et al. HIV, AIDS and Injection Drug Use. A National Action Plan. Ottawa; National Task Force o HIV, AIDS and Injection Drug Use. 1997.
3. Fischer B, Rehm J. The case for a heroin substitution treatment trial in Canada. Can J Public Health 1997;88(6):367-70.
4. Millar JS. HIV, Hepatitis, and Injection Drug Use in British Columbia: Pay Now or Pay Later? British Columbia: Ministry of Health and Ministry Responsible for Seniors, 1998.
5. National Institute of Health National Consensus Development Panel on Effective Medical Treatment of Opiate Addiction. Effective Medical Treatment of Opiate Addiction. JAMA 1998;280:1936-43.
6. National Institute on Drug Abuse. Methadone Maintenance Treatment: Translating Research into Policy. 1995.
7. Bruneau J, Lamothe F, Franco E, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study. Am J Epidemiol 1997;146(12):992-1002.
8. Strathdee S, Patrick D, Currie S, et al. Needle exchange is not enough: Lessons from the Vancouver injecting drug use study. AIDS 1997;11:F59-F65.
9. Fischer B, Medved W, Rehm J, Gliksman L. Profile of illicit and un-treated opiate users in Toronto, Canada. Addiction Research (in press).
10. Wall R, Rehm J, Fischer B, et al. The social cost of un-treated opiate use. Health Economics (under review).
11. Ward J, Hall W, Mattick R. Role of methadone maintenance in opioid dependence. Lancet 1999;353:221-26.
12. Bertschy G. Methadone maintenance treatment: An update. Eur Arch Psychiatry Clin Neurosci 1995;245:114-24.
13. Ralston G, Wilson P. Methadone programs - The costs and benefits to society. Pharmaco Economics 1996;10(4):321-26.
14. Institute of Medicine. Federal Regulation of Methadone Treatment. Washington, DC: National Academy Press, 1995.
15. Senay E, Uchtenhagen A. Methadone in the Treatment of Opioid Dependence: A Review of the World Literature. New York: Praeger, 1990.
16. Ball JC, Lange W, Myres C, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav 1988;29:214-26.
17. Simpson DD, Joe GW, Bracy SA. Six year follow-up of opioid addicts after admission to treatment. Arch Gen Psychiatry 1982;39:1318-23.
18. Fischer B. Prescriptions, power and politics: The turbulent history of methadone maintenance in Canada. J Public Health Policy (in press).
19. Newman R, Whitehill WB. Double blind comparison of methadone and placebo maintenance treatments of narcotic addicts in Hong Kong. Lancet 1979;September(8):485-88.
20. Grönbladh L, Ohlund LS, Gunne LM. Mortality in heroin addiction: Impact of methadone treatment. Acta Psychiatr Scand 1990;82:223-27.
21. Torrens M, Domingo-Salvany A, Alonso J, et al. Methadone and quality of life. Lancet 1999;353:1101.
22. Smart R, Everson A, Segal R, et al. A four-year follow-up study of narcotic-dependent persons receiving methadone maintenance substitution therapy. Can JPublic Health 1977;68:55-58.